Seladelpar: an investigational drug for the treatment of early-stage primary biliary cholangitis (PBC). (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/13543784.2022.2130750
PubMed Identifier: 36194037
Publication URI: http://europepmc.org/abstract/MED/36194037
Type: Journal Article/Review
Volume: 31
Parent Publication: Expert opinion on investigational drugs
Issue: 10
ISSN: 1354-3784